跳至主要内容
临床试验/CTRI/2021/02/031157
CTRI/2021/02/031157已完成不适用

Evaluation of irritation potential of Silever Face Wash through dermatological Evaluation by single occlusive patch test on Healthy adult human volunteers.

Everclean Technologies Pvt Ltd1 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2021年10月2日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
24
试验地点
1
主要终点
Evaluation of mean scores of Erythema/dryness/wrinkles, Oedema and Mean Irritation Index

研究概览

简要总结

24adulthealthy subjects will be selected for the study. The subjects selected for thisstudy will be healthy females and males, aged between 18 and 55 years old. In which 12 willbe females and 12 will be male subjects. The entire study procedure, patchapplication, patch reading and grading is detailed in the protocol and followedas per the protocol. The Patch applied contain Finn’s chamber within which 2drops of the test product will be filled in a separate chamber.The patch is applied on the back or shoulder area of the subjects and will bein contact with the skin for 24 hours. If the subject experiences any allergicreaction, the patch can be removed within 24 hours and reported to theinvestigator immediately. The mean scores of  Erythema/dryness/wrinkles, Oedema and  MeanIrritation Index will be calculated on day 1,2,3 and 8.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 55.00 Year(s)(—)
性别
All

入选标准

  • Healthy subjects with healthy skin on the studied anatomic unit (free of eczema, wounds & any other inflammatory scar)
  • Age group of 18 to 55 years, 12 male and 12 female subjects.
  • Compliance with the study procedures involved.

排除标准

  • 1.Pregnant and lactating women 2.Subjects with any other skin disorders.
  • 3.Use of any other topical agents for any skin related conditions (at the site of application of patch) during the past 30 days.

结局指标

主要结局

Evaluation of mean scores of Erythema/dryness/wrinkles, Oedema and Mean Irritation Index

时间窗: Day 1,2,3 and 8

次要结局

  • occurrence of any adverse effects.(day 1,2,3 and 8)

研究者

发起方
Everclean Technologies Pvt Ltd
申办方类型
Pharmaceutical industry-Indian

研究点 (1)

Loading locations...

相似试验